Skip to content
Home/Companies/MedTech/Immed
Immed

Immed

MedTech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Immed?

Immed is a French MedTech company, currently owned by Isatis Capital since 2022.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Isatis Capital
Investor
Isatis Capital
FCPR Isatis Capital Vie & Retraite · 2017 · Growth

Key facts

HQFrance
SectorMedTech
Websitewww.immed.net

More from FCPR Isatis Capital Vie & Retraite

Other portfolio companies in the same fund.

Consortium Ménager Parisien (CMP Paris)
Exited 2017
ConsumerFrance
to Tirman family
DiaDom
DiaDom
Exited 2018
HealthcareFrance
to La Poste Groupe
M-Cube France
Exited 2019
SoftwareFrance
to M-Cube
Adelyce
Active
HR TechFrance· 2026
Captivea
Active
IT ServicesFrance· 2026
AXE Informatique
AXE Informatique
Active
IT ServicesFrance· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Immed?

Immed is currently owned by Isatis Capital, through FCPR Isatis Capital Vie & Retraite, since 2022.

When did Isatis Capital acquire Immed?

Isatis Capital acquired Immed in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue